Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer

Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer. However, before NRG-HN009, there was limited randomized evidence to determine which regimen provided the best balance of cancer control and treatment-related side effects.

source https://medicalxpress.com/news/2026-09-weekly-cisplatin-side-effects-p16.html